Friday 6/28 Insider Buying Report: BSTZ, TGTX (Nasdaq.com)
On Tuesday, Blackrock Science and Technology Trust II (BSTZ)’s , Tony Kim, made a $540,000 purchase of BSTZ, buying 27,000 shares at a cost of $20.00 a piece. So far Kim is in the green, up about 0.4% on their purchase based on today’s trading high of $20.09. Blackrock Science and Technology Trust II is trading up about 0.1% on the day Friday. This buy marks the first one filed by Kim in the past year. And at TG Therapeutics (TGTX), there was insider buying on Wednesday, by CEO and President Michael S. Weiss who bought 50,000 shares for a cost of $7.04 each, for a trade totaling $351,750. TG Therapeutics is trading up about 0.2% on the day Friday. Weiss was up about 14.7% on the buy at the high point of today’s trading session, with TGTX trading as high as $8.07 at last check today.
What Did This CEO Just Do with Personal Shares of Alphabet Inc (NASDAQ: GOOGL)? (Analyst Ratings)
Today, the CEO, Google LLC of Alphabet Inc (GOOGL), Sundar Pichai, sold shares of GOOGL for $9.45M. Following Sundar Pichai’s last GOOGL Sell transaction on September 29, 2015, the stock climbed by 454.0%. In addition to Sundar Pichai, one other GOOGL executive reported Sell trades in the last month.
Insider Buying Activity Continues to Rise (The Street – Real Money)
There have been minor technical improvements on the charts of the major equity indices of late. What’s also been notable has been a somewhat impressive rise in insider buying activity over the past few days. Is this enough to shift our outlook for the markets? Let’s take a look. On the Charts: All of the equity indices closed higher Thursday with the exception of the DJIA, which posted a minor decline. Internals were positive on the NYSE and Nasdaq as trading volumes declined from those of the prior session. Some improvements came in the form of the Dow Jones Transports closing above its near-term downtrend line, changing its trend to neutral. The S&P MidCap 400 and Value Line Arithmetic Index closed back above their 50-day moving averages. No support or resistance levels were violated.
Largest Insider Trades of the Week (Guru Focus)
Armistice Capital Master Fund bought 498,016 shares of AMAG Pharmaceuticals Inc. (NASDAQ:AMAG) for an average price of $8.87 per share on June 27. The company, which develops therapeutic compounds to treat anemia, has a market cap of $321.80 million and an enterprise value of $320.85 million. It has insider ownership of 5.51% and institutional ownership of 87.27%. Over the last 12 months, the stock has fallen 51% and is now trading 63.49% below its 52-week high and 22.02% above its 52-week low.
Former Equifax Exec Sentenced to 4 Months in Prison for Insider Trading Related to Data Breach (Market Watch)
ATLANTA – A former Equifax executive who sold stock a week and a half before the company announced a massive data breach was sentenced Thursday to serve four months in federal prison for insider trading. Jun Ying, former chief information officer of Equifax’s U.S. Information Solutions, pleaded guilty in March. His prison time is to be followed by a year of supervised release, and he was also ordered to pay about $117,000 in restitution and a $55,000 fine, the U.S. attorney’s office in Atlanta said in a news release.
Indian IT Contractor to Pay $800k in Penalties Over Insider Trading Charges (Business Standard)
An Indian IT contractor has agreed to settle insider trading charges brought against him by the Securities and Exchange Commission (SEC) by paying nearly $800,000 in penalties. Rajeshwar Gannamaneni, 36 is a citizen of India with a last known residence in Singapore. In December last year, the SEC charged Gannameneni with securities fraud based on his role in a serial insider trading scheme, and obtained a temporary restraining order freezing his United States assets.
Burner Phones, Leaks to Journalists: Regulators Probe Suspected Insider-Trading Scheme (The Wall Street Journal)
A former Citigroup Inc. employee was the alleged middleman in what authorities believe may be an insider trading scheme, according to people familiar with the matter and disclosures in a U.K. court case that wrapped up Thursday. The U.K.’s Financial Conduct Authority is investigating whether David Johnson, who left Citi in 2013, collected details about impending deals from a former colleague and passed them to traders, the people say. The Securities and Exchange Commission is investigating the allegations, the people say…
